To advance faculty research and enhance the commercialization of Indiana University innovations, the IU Innovation and Commercialization Office has awarded the Lawrence Blatt Endowed Fund for Translational Research to Adarsh Dharan, an assistant professor of biology at IU Bloomington. The Lawrence Blatt Endowed Fund for Translational Research is designed to support the development of translational… Read more »
Tag: therapeutics
IU faculty startup MBX Biosciences announces $163.2 million U.S. IPO
MBX Biosciences, an Indiana University faculty-created startup that develops peptide therapies for the treatment of endocrine and metabolic diseases, raised $163.2 million in its U.S. initial public offering. The company’s peptides are based on chemistry developed by a research team led by Richard DiMarchi, scientific cofounder of MBX Biosciences and Distinguished Professor of Chemistry in… Read more »
IU researchers create gene therapeutic for the treatment of inherited genetic diseases
Despite significant improvements in gene therapy in recent years, there are still major drawbacks such as the lack of development of more accessible gene therapies for those with inherited genetic diseases due to a missing or defective gene or gene product. For those individuals, there are limited individualized therapies geared toward their genetic makeup. Weidong… Read more »